TipRanks
Reckon Health Care Holdings Ltd (AU:GGR)
ASX:GGR
Australian Market
Want to see AU:GGR full AI Analyst Report?

Reckon Health Care Holdings Ltd (GGR) AI Stock Analysis

0 Followers

Top Page

AU:GGR

Reckon Health Care Holdings Ltd

(Sydney:GGR)

Select Model
Select Model
Select Model
Neutral 44 (OpenAI - Gpt-5.6Sol)
Rating:44Neutral
Price Target:
AU$0.13
▼(-37.00% Downside)
Action:Reiterated
Date:10/07/26
The score is primarily weighed down by weak financial performance (minimal revenue, widening losses, and worsening cash burn) and a downtrending technical picture (price below key moving averages with negative MACD). Valuation provides limited support due to negative earnings (negative P/E) and no dividend yield data.
Positive Factors
Low Leverage
Zero total debt in 2026 and modest leverage in other years reduce interest and refinancing pressure. This gives the company greater financial flexibility than a highly indebted peer, although that advantage is tempered by continued losses and the need to fund operations.
Negative Factors
Pre-Revenue Position
A largely pre-revenue operating profile indicates the company has not yet demonstrated durable commercial traction. Without meaningful recurring revenue, fixed costs and development spending are harder to absorb, while future operations remain dependent on achieving substantial revenue conversion.
Read all positive and negative factors
Positive Factors
Negative Factors
Low Leverage
Zero total debt in 2026 and modest leverage in other years reduce interest and refinancing pressure. This gives the company greater financial flexibility than a highly indebted peer, although that advantage is tempered by continued losses and the need to fund operations.
Read all positive factors

Reckon Health Care Holdings Ltd (GGR) vs. iShares MSCI Australia ETF (EWA)

Reckon Health Care Holdings Ltd Business Overview & Revenue Model

Company Description
Golden Globe Resources Ltd. (GGR.AX) is an Australian mineral exploration company focused on discovering and developing copper and gold resources. The firm maintains full ownership of the Dooloo Creek Project, which includes two exploration permit...

Reckon Health Care Holdings Ltd Financial Statement Overview

Summary
Income statement and cash flow are very weak: the company is effectively pre-revenue with persistent and widening losses, and operating/free cash flow are consistently negative with a sharply worsening burn in the latest year. The balance sheet is a partial offset due to low/no debt and a stronger equity base, but ongoing losses and cash burn elevate funding and durability risk.
Income Statement
8
Very Negative
Balance Sheet
58
Neutral
Cash Flow
12
Very Negative
BreakdownJun 2026Dec 2024Jun 2024Jun 2023Jun 2022
Income Statement
Total Revenue0.000.000.007.64K0.00
Gross Profit-685.000.000.007.64K0.00
EBITDA-2.10M0.000.00-1.20M-1.20M
Net Income-2.23M-1.81M-1.16M-1.39M-1.49M
Balance Sheet
Total Assets8.48M2.55M2.35M2.96M3.69M
Cash, Cash Equivalents and Short-Term Investments3.55M261.65K1.36K189.50K1.07M
Total Debt0.00389.86K253.00K0.0037.50K
Total Liabilities517.89K1.38M678.14K205.41K119.17K
Stockholders Equity7.96M1.18M1.67M2.75M3.57M
Cash Flow
Free Cash Flow-2.12M-546.49K-479.95K-1.28M-1.71M
Operating Cash Flow-2.11M-482.67K-373.72K-1.08M-1.16M
Investing Cash Flow-2.60M-47.70K110.08K-329.26K-557.37K
Financing Cash Flow8.00M790.65K75.50K530.73K1.68M

Reckon Health Care Holdings Ltd Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.20
Price Trends
50DMA
0.15
Positive
100DMA
0.16
Positive
200DMA
0.21
Negative
Market Momentum
MACD
<0.01
Negative
RSI
65.94
Neutral
STOCH
76.19
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:GGR, the sentiment is Positive. The current price of 0.2 is above the 20-day moving average (MA) of 0.14, above the 50-day MA of 0.15, and below the 200-day MA of 0.21, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 65.94 is Neutral, neither overbought nor oversold. The STOCH value of 76.19 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:GGR.

Reckon Health Care Holdings Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
44
Neutral
AU$22.75M-6.30-26.92%――-24.03%
41
Neutral
AU$392.66M-18.60-128.49%―-9.28%-25.66%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:GGR
Reckon Health Care Holdings Ltd
0.16
>-0.01
-1.82%
AU:EIQ
EchoIQ Limited
0.53
0.33
165.00%

Reckon Health Care Holdings Ltd Corporate Events

Golden Globe Resources Rectifies Late Director Interest Disclosures
Oct 8, 2026
Golden Globe Resources has disclosed that it failed to lodge initial director interest notices for three board members at the time of its admission to the ASX, attributing the omission to an administrative oversight. The company has now submitted ...
Golden Globe Resources Sets Date and Digital Framework for 2026 AGM
Sep 30, 2026
Golden Globe Resources Limited has convened its 2026 Annual General Meeting for 29 October 2026 at 11:00 a.m. AEDT, to be held in person at a North Sydney venue, with meeting materials available online via the company&#8217;s website and ASX platf...
Golden Globe Resources lodges ASX corporate governance statement for FY2026
Sep 23, 2026
Golden Globe Resources Limited has lodged its corporate governance statement and accompanying Appendix 4G with the ASX for the financial year ended 30 June 2026, confirming compliance with disclosure requirements under Listing Rules 4.7.3 and 4.10...
Golden Globe Resources Files 2026 Annual Report
Sep 23, 2026
Golden Globe Resources Limited has released its annual report for the year ended 30 June 2026, detailing the consolidated financial performance, position and cash flows of the group. The report, authorised by the board on 23 September 2026, unders...
Golden Globe Resources Confirms Copper-Gold Systems at Dooloo Creek
Jul 29, 2026
Golden Globe Resources reported that Phase 1 diamond drilling at its Dooloo Creek Project in Queensland successfully confirmed copper-gold mineralisation at the Northern Gold and Eastern Breccia prospects. The program validated the company&#8217;s...
Golden Globe strikes high-grade copper as drilling advances across Queensland portfolio
Jul 27, 2026
Golden Globe Resources Ltd is an Australia-listed copper and gold explorer focused on large-scale intrusive-related and porphyry-style systems in Queensland and the Lachlan Fold Belt. Its projects include Dooloo Creek, Ridler Creek and Neila Creek...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 07, 2026